About
Jakavi 5mg tablet contains ruxolitinib, an anticancer medication classified as a kinase inhibitor. It is primarily used to treat myelofibrosis, a rare bone marrow cancer that reduces the production of blood cells. Jakavi is also prescribed for patients with polycythemia vera—a type of blood cancer characterized by the overproduction of red blood cells—especially in those who cannot tolerate or do not respond well to hydroxyurea.
Additionally, Jakavi is indicated for the treatment of acute graft-versus-host disease (GVHD) in adults and children aged 12 years and older who have not responded to corticosteroid therapy. It is also used to manage chronic GVHD in the same age group when one or two previous systemic treatments have failed.
This medication works by blocking specific signals that encourage cancer cell growth and proliferation. You should not take Jakavi if you are allergic to ruxolitinib or any of its ingredients. Inform your doctor if you have a history of tuberculosis, hepatitis B or C, liver disease, or kidney problems. Also, let your physician know if you are undergoing dialysis. Common side effects include dizziness, low blood cell counts, bruising, bleeding, headaches, and swelling of the face or body.
Uses
- Acute-graft-versus host disease
- Chronic-graft-versus host disease
- Myelofibrosis
- Polycythemia vera
Directions for use
This medicine will be administered by your doctor or nurse. Please do not attempt to self-administer it.
Side effects
- Diarrhea
- Infections, including viral infection
- Swelling in the face and body
- Fatigue or tiredness
- Severe infections like hepatitis B
- Anemia
- Bleeding
- Low red and white blood cell counts
- Low platelet counts
- Dizziness, headache
- Bruising
Safety Measures
Alcohol - It is not known whether drinking alcohol is safe while taking Jakavi 5mg tablets. Inform your doctor if you consume alcohol regularly or have a history of alcohol use before beginning treatment.
Pregnancy - Avoid taking Jakavi 5mg tablets during pregnancy, as it may harm the developing baby. Inform your doctor if you are pregnant, think you might be pregnant, or are planning to become pregnant while undergoing treatment.
Breastfeeding - Breastfeeding is not advised while taking Jakavi 5mg tablets, as small amounts of the medication can pass into breast milk and may harm your baby. You should avoid breastfeeding during treatment and for at least 2 weeks after your final dose.
Liver - Jakavi 5mg tablets should be used with caution in individuals with liver conditions, as dose adjustments may be required. Be sure to inform your doctor if you have any liver-related disorders before starting treatment.
Kidney - Jakavi 5mg tablets should be used with caution in patients with kidney problems, as the drug is partly eliminated through the kidneys. Dose adjustments may be needed in cases of impaired kidney function. Inform your doctor if you have any kidney-related issues before starting treatment.
Disclaimer
Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!